EXCEDRIN

This brand name is authorized in Ireland, Israel, Mexico, Netherlands, Poland, South Africa

Active ingredients

The drug EXCEDRIN contains a combination of these active pharmaceutical ingredients (APIs):

1 Acetylsalicylic acid UNII R16CO5Y76E - ASPIRIN

Acetylsalicylic acid combines significant advantages such as strong anti-pyretic, analgesic and anti-inflammatory action, that is the measure of comparison with all the newer NSAIDs. Read about Acetylsalicylic acid

2 Paracetamol UNII 362O9ITL9D - ACETAMINOPHEN

Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain. Read about Paracetamol

3 Caffeine UNII 3G6A5W338E - CAFFEINE

Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant. Read about Caffeine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N02BA51	Acetylsalicylic acid, combinations excl. psycholeptics	N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BA Salicylic acid and derivatives
Discover more medicines within N02BA51
N02BE51	Paracetamol, combinations excl. psycholeptics	N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BE Anilides
Discover more medicines within N02BE51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 5406, 5485
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 273M98
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 105961
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100223056
Country: ZA	Health Products Regulatory Authority	Identifier(s): 36/2.7/0183